ODDB.org: Open Drug Database

Teva Pharma AG - Cinqaero 25 mg/2,5 mL, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	66340	Sequence	02
Product name	Cinqaero 25 mg/2,5 mL	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	R03DX08	ATC-Description	Reslizumab
Introduction of Sequence	12.07.2018

Composition

reslizumabum 25 mg, saccharum, natrii acetas trihydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 2.5 ml corresp. natrium 0.35 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Reslizumabum	25mg / 2.5ml

BAG: Active Agent	Dose
Reslizumabum	25 mg

Inactive agents
Acidum Aceticum Glaciale
Sodium Acetate Trihydrate
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002		141.81	170.65	B	SL	Yes

2025	©ywesee GmbH